HARVARD BIOSCIENCE INC — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2021-05-25

Reporting Person: EDRICK ALAN I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-25	Common Stock	A	14400	$0.00	Acquired	130300	Direct

Footnotes

F1: Represents an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022.

F2: Includes (a) the award described in footnote (1) above, (b) an award of 12,225 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2021, September 30, 2021 and December 31, 2021, and (c) 103,675 shares of common stock held by the Reporting Person.